Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease
暂无分享，去创建一个
R. Elashoff | V. Sondak | D. Elashoff | A. Cochran | H. Hoekstra | B. Coventry | D. Roses | M. Kashani-Sabet | O. Nieweg | M. Faries | S. Stern | L. Foshag | Manabu Fujita | A. Uppal | J. Thompson | Nicola Mizzollo | Myung Sim-Shin
[1] A. Hauschild,et al. Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600–Mutant Stage III Melanoma , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Schadendorf,et al. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma , 2018, The New England journal of medicine.
[3] A. Gesierich,et al. Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.
[4] R. Elashoff,et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.
[5] H. Gutman,et al. Patterns of recurrence in patients with melanoma after radical lymph node dissection. , 2006, Archives of surgery.
[6] D. Tyler,et al. Long-Term Survival in 2,505 Patients With Melanoma With Regional Lymph Node Metastasis , 2002, Annals of surgery.
[7] J. Gibbs,et al. Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma , 2001, Annals of Surgical Oncology.
[8] S. Singletary,et al. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. , 1989, Archives of surgery.
[9] S. Fisher. Cutaneous malignant melanoma of the head and neck , 1989, The Laryngoscope.